Commonwealth Equity Services’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-51,203
| Closed | -$51K | – | 3852 |
|
|
2021
Q4 | $51K | Buy |
+51,203
| New | +$51K | ﹤0.01% | 3530 |
|
|
2019
Q2 | – | Sell |
-1,539
| Closed | -$4K | – | 2856 |
|
|
2019
Q1 | $4K | Hold |
1,539
| – | – | ﹤0.01% | 2740 |
|
|
2018
Q4 | $3K | Hold |
1,539
| – | – | ﹤0.01% | 2673 |
|
|
2018
Q3 | $7K | Hold |
1,539
| – | – | ﹤0.01% | 2779 |
|
|
2018
Q2 | $7K | Hold |
1,539
| – | – | ﹤0.01% | 2755 |
|
|
2018
Q1 | $11K | Buy |
1,539
+10
| +0.7% | +$71 | ﹤0.01% | 2694 |
|
|
2017
Q4 | $11K | Hold |
1,529
| – | – | ﹤0.01% | 2662 |
|
|
2017
Q3 | $13K | Sell |
1,529
-75
| -5% | -$638 | ﹤0.01% | 2544 |
|
|
2017
Q2 | $16K | Sell |
1,604
-100
| -6% | -$998 | ﹤0.01% | 2493 |
|
|
2017
Q1 | $20K | Hold |
1,704
| – | – | ﹤0.01% | 2387 |
|
|
2016
Q4 | $22K | Hold |
1,704
| – | – | ﹤0.01% | 2287 |
|
|
2016
Q3 | $31K | Hold |
1,704
| – | – | ﹤0.01% | 2192 |
|
|
2016
Q2 | $18K | Sell |
1,704
-36
| -2% | -$380 | ﹤0.01% | 2207 |
|
|
2016
Q1 | $33K | Hold |
1,740
| – | – | ﹤0.01% | 2152 |
|
|
2015
Q4 | $46K | Sell |
1,740
-50
| -3% | -$1.32K | ﹤0.01% | 2109 |
|
|
2015
Q3 | $82K | Sell |
1,790
-100
| -5% | -$4.58K | ﹤0.01% | 2008 |
|
|
2015
Q2 | $61K | Hold |
1,890
| – | – | ﹤0.01% | 2120 |
|
|
2015
Q1 | $60K | Hold |
1,890
| – | – | ﹤0.01% | 2107 |
|
|
2014
Q4 | $71K | Sell |
1,890
-100
| -5% | -$3.76K | ﹤0.01% | 2004 |
|
|
2014
Q3 | $53K | Sell |
1,990
-101
| -5% | -$2.69K | ﹤0.01% | 2011 |
|
|
2014
Q2 | $62K | Buy |
2,091
+86
| +4% | +$2.55K | ﹤0.01% | 1975 |
|
|
2014
Q1 | $74K | Buy |
2,005
+75
| +4% | +$2.77K | ﹤0.01% | 1910 |
|
|
2013
Q4 | $80K | Buy |
1,930
+186
| +11% | +$7.71K | ﹤0.01% | 1838 |
|
|
2013
Q3 | $92K | Buy |
1,744
+100
| +6% | +$5.28K | ﹤0.01% | 1763 |
|
|
2013
Q2 | $88K | Buy |
+1,644
| New | +$88K | ﹤0.01% | 1700 |
|